Literature DB >> 34078072

Prescribing Silver Chirality with DNA Origami.

Yinan Zhang1,2, Zhi-Bei Qu1, Chu Jiang3, Yingying Liu1, Raghu Pradeep Narayanan2, Dewight Williams4, Xiaolei Zuo5, Lihua Wang6,7, Hao Yan2, Huajie Liu3, Chunhai Fan1.   

Abstract

Metal nanostructures of chiral geometry interacting with light via surface plasmon resonances can produce tailorable optical activity with their structural alterations. However, bottom-up fabrication of arbitrary chiral metal nanostructures with precise size and morphology remains a synthetic challenge. Here we develop a DNA origami-enabled aqueous solution metallization strategy to prescribe the chirality of silver nanostructures in three dimensions. We find that diamine silver(I) complexes coordinate with the bases of prescribed single-stranded protruding clustered DNA (pcDNA) on DNA origami via synergetic interactions including coordination, hydrogen bonds, and ion-π interaction, which induce site-specific pcDNA condensation and local enrichment of silver precursors that lowers the activation energy for nucleation. Using tubular DNA origami-based metallization, we obtain helical silver patterns up to a micrometer in length with well-defined chirality and pitches. We further demonstrate tailorable plasmonic optical activity of metallized chiral silver nanostructures. This method opens new pathways to synthesize programmable inorganic materials with arbitrary morphology and chirality.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34078072     DOI: 10.1021/jacs.1c00363

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  2 in total

Review 1.  DNA Nanotechnology-Enabled Fabrication of Metal Nanomorphology.

Authors:  Mo Xie; Yang Hu; Jue Yin; Ziwei Zhao; Jing Chen; Jie Chao
Journal:  Research (Wash D C)       Date:  2022-06-14

Review 2.  Engineering Inorganic Materials with DNA Nanostructures.

Authors:  Amelie Heuer-Jungemann; Veikko Linko
Journal:  ACS Cent Sci       Date:  2021-11-18       Impact factor: 14.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.